期刊
VIRUS EVOLUTION
卷 7, 期 1, 页码 -出版社
OXFORD UNIV PRESS
DOI: 10.1093/ve/veab007
关键词
virus evolution; viral ecology; recombination; coronavirus
类别
资金
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI149693]
- Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
- National Institutes of Health (NIH) [U19AI142777]
- United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project [GHN-A-OO-09-00010-00, AID-OAA-A-14-00102]
The study introduced a novel sarbecovirus from Rwanda and Uganda, which is phylogenetically intermediate to SARS-CoV-1 and SARS-CoV-2 and is unable to utilize human ACE2. The findings suggest that the observed pattern of ACE2 usage among sarbecoviruses is best explained by recombination of SARS-CoV-1 and its relatives, shedding light on the natural history of ACE2 usage for both SARS-CoV-1 and SARS-CoV-2.
Severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and SARS-CoV-2 are not phylogenetically closely related; however, both use the angiotensin-converting enzyme 2 (ACE2) receptor in humans for cell entry. This is not a universal sarbecovirus trait; for example, many known sarbecoviruses related to SARS-CoV-1 have two deletions in the receptor binding domain of the spike protein that render them incapable of using human ACE2. Here, we report three sequences of a novel sarbecovirus from Rwanda and Uganda that are phylogenetically intermediate to SARS-CoV-1 and SARS-CoV-2 and demonstrate via in vitro studies that they are also unable to utilize human ACE2. Furthermore, we show that the observed pattern of ACE2 usage among sarbecoviruses is best explained by recombination not of SARS-CoV-2, but of SARS-CoV-1 and its relatives. We show that the lineage that includes SARS-CoV-2 is most likely the ancestral ACE2-using lineage, and that recombination with at least one virus from this group conferred ACE2 usage to the lineage including SARS-CoV-1 at some time in the past. We argue that alternative scenarios such as convergent evolution are much less parsimonious; we show that biogeography and patterns of host tropism support the plausibility of a recombination scenario, and we propose a competitive release hypothesis to explain how this recombination event could have occurred and why it is evolutionarily advantageous. The findings provide important insights into the natural history of ACE2 usage for both SARS-CoV-1 and SARS-CoV-2 and a greater understanding of the evolutionary mechanisms that shape zoonotic potential of coronaviruses. This study also underscores the need for increased surveillance for sarbecoviruses in southwestern China, where most ACE2-using viruses have been found to date, as well as other regions such as Africa, where these viruses have only recently been discovered.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据